OAJ
WST icon

Ogorek Anthony Joseph’s West Pharmaceutical WST Stock Holding History

Ogorek Anthony Joseph’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-140
Closed -$36K – 702
2025
Q3 		$36K Sell
140
-40
-22% -$9.72K 0.01% 198
2025
Q2 		$39K Hold
180
– – 0.01% 184
2025
Q1 		$40K Hold
180
– – 0.01% 179
2024
Q4 		$59K Hold
180
– – 0.02% 108
2024
Q3 		$54K Hold
180
– – 0.02% 113
2024
Q2 		$59K Hold
180
– – 0.02% 98
2024
Q1 		$71K Hold
180
– – 0.02% 90
2023
Q4 		$63K Hold
180
– – 0.02% 94
2023
Q3 		$67K Hold
180
– – 0.03% 97
2023
Q2 		$68K Hold
180
– – 0.03% 91
2023
Q1 		$62K Buy
+180
New +$52.6K 0.03% 92

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Ogorek Anthony Joseph's WST Position: Q4 2025 in Review

Ogorek Anthony Joseph sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 140 shares — an estimated $36K sold.

Ogorek Anthony Joseph first reported a position in WST in Q1 2023 and held it in 11 quarters. The position peaked at $71K in Q1 2024. 804 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • Ogorek Anthony Joseph reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Ogorek Anthony Joseph sold 140 West Pharmaceutical shares in Q4 2025, an estimated $36K.
  • Ogorek Anthony Joseph first reported a position in West Pharmaceutical in Q1 2023 and held it in 11 quarters.
  • Ogorek Anthony Joseph's West Pharmaceutical position peaked at $71K in Q1 2024.
  • 804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on Ogorek Anthony Joseph's 13F filing for Q4 2025, filed 23 Jan 2026.